Catalent to acquire majority stake in Zhejiang Jiang Yuan Tang Biotechnology - MarketLine Financial Deals

Catalent to acquire majority stake in Zhejiang Jiang Yuan Tang Biotechnology

Catalent to acquire majority stake in Zhejiang Jiang Yuan Tang Biotechnology - MarketLine Financial Deals
Catalent to acquire majority stake in Zhejiang Jiang Yuan Tang Biotechnology
Published Mar 11, 2013
2 pages — Published Mar 11, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Catalent Pharma Solutions, Inc., a US-based provider of drug development solutions and advanced delivery technologies for pharmaceutical, biologic and consumer health products, has agreed to acquire a majority stake in Zhejiang Jiang Yuan Tang Biotechnology Co., Ltd., a China-based producer of nutritional softgel products.

  
Source:
Document ID
MA140012_130626
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Catalent to acquire majority stake in Zhejiang Jiang Yuan Tang Biotechnology" Mar 11, 2013. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Catalent-to-acquire-majority-stake-in-Zhejiang-Jiang-Yuan-Tang-Biotechnology-2052-95546>
  
APA:
MarketLine Financial Deals. (2013). Catalent to acquire majority stake in Zhejiang Jiang Yuan Tang Biotechnology Mar 11, 2013. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Catalent-to-acquire-majority-stake-in-Zhejiang-Jiang-Yuan-Tang-Biotechnology-2052-95546>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.